ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Cresco Labs Inc (QX)

Cresco Labs Inc (QX) (CRLBF)

2.07
-0.16
(-7.17%)
Closed March 29 04:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.07
Bid
2.04
Ask
2.22
Volume
948,078
2.05 Day's Range 2.25
1.00 52 Week Range 2.77
Market Cap
Previous Close
2.23
Open
2.25
Last Trade
4
@
2.04
Last Trade Time
Financial Volume
$ 2,053,865
VWAP
2.1663
Average Volume (3m)
974,078
Shares Outstanding
337,473,317
Dividend Yield
-
PE Ratio
-3.29
Earnings Per Share (EPS)
-0.63
Revenue
842.68M
Net Profit
-212.05M

About Cresco Labs Inc (QX)

Sector
Pharmaceutical Preparations
Industry
Gold Ores
Headquarters
Vancouver, British Columbia, Can
Founded
2018
Cresco Labs Inc (QX) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker CRLBF. The last closing price for Cresco Labs (QX) was $2.23. Over the last year, Cresco Labs (QX) shares have traded in a share price range of $ 1.00 to $ 2.77.

Cresco Labs (QX) currently has 337,473,317 shares outstanding. The market capitalization of Cresco Labs (QX) is $698.57 million. Cresco Labs (QX) has a price to earnings ratio (PE ratio) of -3.29.

CRLBF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.031.470588235292.042.261.986314832.14318831CS
40.3218.28571428571.752.261.497510011.85873851CS
120.6242.75862068971.452.681.459740782.05515002CS
260.062.985074626872.012.681.05528001161.83457454CS
520.5334.41558441561.542.7717526821.79344522CS
156-10.33-83.306451612912.413.6516646694.55518683CS
260-8.805-80.965517241410.87518.0616532006.20242683CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVTXAvalo Therapeutics Inc
$ 22.08
(364.84%)
31.9M
NXLNexalin Technologies Inc
$ 1.50
(92.31%)
11.67M
CEROCERo Therapeutics Holdings Inc
$ 3.112
(90.92%)
24.08M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
KYCHKeyarch Acquisition Corporation
$ 12.30
(75.58%)
196.62k
BOLDBoundless Bio Inc
 14.25
(-76.24%)
767.63k
PMECPrimech Holdings Ltd
$ 1.2999
(-66.50%)
8.28M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.1816
(-44.45%)
21.92M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
NBSTWNewbury Street Acquisition Corporation
$ 0.042279
(-38.28%)
1.75k
NKLANikola Corporation
$ 1.035
(13.85%)
163.84M
GMDAGamida Cell Ltd
$ 0.036
(-39.19%)
89.18M
BDRXBiodexa Pharmaceuticals PLC
$ 1.6201
(88.60%)
88.37M
MARAMarathon Digital Holdings Inc
$ 22.56
(2.22%)
86.14M
AKANAkanda Corporation
$ 0.1166
(-29.29%)
80.34M

CRLBF Discussion

View Posts
hyborianwar hyborianwar 2 days ago
load
👍️0
BackTheTruckUp BackTheTruckUp 3 weeks ago
Cresco could potentially be going to $50 / share. Doubters get proven wrong all the time. Remember what TL#Y did years ago? Went to $250 then back down probably because it was too soon before MJ rescheduling and banking reform. The time is now. Rescheduling is coming. So, BackTheTruckUp and load up on Cresco maybe, before the truck leaves the loading zone. Just press that Green buy button. You know you want to. 71 dispensaries in 6 states so far I think.
👍️0
Bazwar6 Bazwar6 4 weeks ago
https://www.marketbeat.com/instant-alerts/otcmkts-crlbf-options-data-report-2024-03-03/
👍️0
make it happen make it happen 2 months ago
All retailers and some semi conductors will flood into cannabis. Ie. Abercrombie & Fitch Lululemons, just to name a couple retailers imho

Feel these names are going to heavy sell for re-balancing/profiting for books (underway past month). Upwards of 500% in a year
👍️0
retired early retired early 4 months ago
It's all about sales and with things opening up, hoping for a turn around in financials :)
👍️0
Green Pharms Green Pharms 5 months ago
Big money coming in
👍️0
Nelson2 Nelson2 5 months ago
Cresco big player in Ohio where recreational weed voted in!
Let’s goooooooo!

GLTA
👍️0
Sanibel Island Sanibel Island 6 months ago
Tim Seymour is recommending US msos but says safe banking further down the road . Seymour recommends TSX listings that have nasdaq listings, HITI . See Tim on YouTube he is a leader on the industry HITide continues up with his recommendation
👍️ 1
-Kush- -Kush- 7 months ago
Heating up, plenty of catalysts on the horizon.
$CL
$CRLBF
👍️0
$5.95akadawson-m $5.95akadawson-m 7 months ago
2 weeks ago the stock price was $1.05!
👍️0
cootcat cootcat 7 months ago
I like, to see every CRLBF share buy some CCHWF shares. Making CRLBF share hold a force in CCHWF
👍️0
retired early retired early 8 months ago
OK who' got the match? :)
👍️0
JohnCM JohnCM 10 months ago
Looking good!
👍️0
retired early retired early 10 months ago
Cresco start your engines. :)
👍️0
KingOfSwing...Trading KingOfSwing...Trading 11 months ago
I like the sound of that!
👍️0
abrooklyn abrooklyn 11 months ago
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

https://www.otcmarkets.com/otcapi/company/financial-report/362380/content



👍️0
$5.95akadawson-m $5.95akadawson-m 11 months ago
Or maybe the fusion of Columbia Care into Cresco
👍️0
cardvic cardvic 11 months ago
Don't get me wrong. I hope this is the beginning of the cannabis comeback.
👍️0
$5.95akadawson-m $5.95akadawson-m 11 months ago
:))
👍️0
retired early retired early 11 months ago
Pin drop :)
👍️0
retired early retired early 1 year ago
The Debby downer is spreading his wings. :)
👍️0
BackTheTruckUp BackTheTruckUp 1 year ago
:)
👍️0
$5.95akadawson-m $5.95akadawson-m 1 year ago
How many mj boards have you posted that same sentence?
👍️0
cardvic cardvic 1 year ago
Cannabis stocks continue their march to oblivion, courtesy of shorty, with no end in sight. Anyone waiting for politicians to save them better head for the life rafts.
👍️0
Ultimate Weapon Ultimate Weapon 1 year ago
Politicians takin us to the wood shed......
👍️0
$5.95akadawson-m $5.95akadawson-m 1 year ago
I've been saying the same thing; however, every MSO has gone down precipitously in the past week. Now that NO bill will be passed for banking measures for mj companies, we tread water as usual.
👍️0
treedoc treedoc 1 year ago
Holy smokes! What happened here?
👍️0
retired early retired early 1 year ago
Times changing for Cresco. :)
👍️0
StockLogistics StockLogistics 1 year ago
Too much debt too many shares :

“As of September 30, 2022, current assets were $355 million, including cash and cash equivalents of $130 million. The Company had working capital of $85 million and senior secured term loan debt, net of discount and issuance costs, of $380 million.Total shares on a fully converted basis were 437,484,245 as of September 30, 2022.”
👍️0
nickwill69 nickwill69 1 year ago
up a dollar a share since you posted this.
👍️0
nickwill69 nickwill69 1 year ago
wow
👍️0
Ronin Ronin 1 year ago
Which bill? Which committee?

I just read where Schumer's bill got shot down in Senate but they have another in the wings before the upcoming election that has bipartisan agreement to allow pharmas to expand research on marijuana

https://www.marijuanamoment.net/schumer-touts-senate-marijuana-research-bill-among-historic-progress-under-biden-as-legalization-measure-lingers/

According to Sen. Cory Booker (D-NJ), a prime sponsor of CAOA, recently said that the so-called “SAFE Banking Plus” bill that’s in the works would likely be filed following the elections during the lame duck session.

In the meantime, Senate Democrats have the bipartisan marijuana research bill as the main example of cannabis reform progress since President Joe Biden took office and Democrats reclaimed the majority in the Senate.

That specific legislation hasn’t been enacted into law, though. But there are hopes that a slightly revised version that was introduced last month could reach the president’s desk in due time. It already cleared the House just days after its filing, and sources say the Senate is expected to act shortly.
👍️0
StockLogistics StockLogistics 1 year ago
2.41 intraday gap fill by Thursday imo charts look good after that, legalization passed committee
👍️0
Nelson2 Nelson2 2 years ago
And this

“Toronto, Ontario--(Newsfile Corp. - Le 20 septembre/September 2022) - Cresco Labs Inc - Subordinate Voting Share Purchase Warrants listed on September 24, 2019 will expire on September 24, 2022.
Settlement Terms: All trades September 21 and 22 will settle for cash next day. Trades on September 23 will be for cash same day.
The warrants will be halted at noon and delisted at market close September 23, 2022.
👍️0
Nelson2 Nelson2 2 years ago
Read this on Yahoo

“The answer is in the wt it stands for warrant … those are old warrants that were listed and sold . If you had one and they didn’t settle in the money then they get trashed .. think of it as a lottery ticket .. you buy that particular type of stock hoping the price shoots up . If it does the warrant type stocks have a contract of execution agreement hooked to them . It states you can buy a stock for a cheaper price. ( if the regular stock market raised past the warrant price) by exchanging the warrant for a set price … if it finishes too low then it isn’t worth exchanging and you toss it away”
👍️0
nunaka nunaka 2 years ago
Thanks for the input.
👍️0
nsomniyak nsomniyak 2 years ago
Could be they are just dropping the Canadian listing to become exclusively US listed?

I believe that is a precondition for an uplist to NASDAQ and therefore I suspect this is a good thing.
👍️0
nunaka nunaka 2 years ago
?????

IIROC Trading Halt - CL.WT
BY Canada NewsWire
— 12:18 PM ET 09/23/2022
VANCOUVER, BC, Sept. 23, 2022 /CNW/ - The following issues have been halted by IIROC:

Company: Cresco Labs Inc. (CRLBF)

CSE Symbol: CL.WT

All Issues: No

Reason: Pending Delisting

Halt Time (ET): 12:00 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.
👍️0
hyborianwar hyborianwar 2 years ago
agreed .. i loaded 3s already to avg down
👍️0
Ronin Ronin 2 years ago
When Fed rolls back restrictions in Fall (as per Schumers new MJ deal to make everyone happy) the Cresco really soars!
👍️0
-Kush- -Kush- 2 years ago
Need uplisting, cresco will be a monster
👍️0
hyborianwar hyborianwar 2 years ago
heavily undervalued .. shorts will get smoked
👍️0
FUNMAN FUNMAN 2 years ago
Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022

STOCKS Aug 2, 2022 • 6:30 AM EDT

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Wednesday, August 17th, 2022, before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.

Event: Cresco Labs Second Quarter 2022 Earnings Conference Call
Date: Wednesday, August 17th, 2022
Time: 8:30am EST
Webcast: Link
Dial-in: 1-844-200-6205 (US Toll Free), 1-833-950-0062 (Canada Toll Free), 1-646-904-5544 (US Local), +1 929-526-1599 (Other)
Access Code: 035060

Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy’s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.



View source version on businesswire.com: https://www.businesswire.com/news/home/20220801005267/en/

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Source: Cresco Labs Inc.
👍️0
retired early retired early 2 years ago
Passing with a vote of 220-204, the MORE Act does not have overwhelming bipartisan support, with only 3 Republican representatives backing the bill.
👍️0
retired early retired early 2 years ago
Company reports 20% year-over-year revenue growth and 45% year-over-year adjusted EBITDA(1) growth -- and continues industry leadership in branded wholesale and retail productivity :)
👍️0
Nelson2 Nelson2 2 years ago
Here you go boyz!

“First Quarter 2022 Financial Highlights
First quarter revenue of $214 million, up 20% year-over-year
Gross profit excluding fair value mark-up for acquired inventory of $113 million, or 53% of revenue, an increase of 29% year-over-year
First quarter adjusted EBITDA1 of $51 million, or 24% of revenue, an increase of 45% year-over-year
Wholesale revenue of $95 million, maintained position as #1 seller of branded cannabis products in U.S. with leading share in the flower, concentrates, and vape categories
Retail revenue increased 44% year-over-year, to $119 million, or $2.5 million per average store open in the quarter and same-store-sales increased 9% year-over-year
Ended the quarter with $179 million of cash on hand
Opened four new retail stores, three in Florida and one in Pennsylvania, bringing the Company’s total retail footprint to 50
Launched branded product portfolio in Florida, including High Supply®, Good News®, Remedi™ and Sunnyside* Chews”
👍️0
Heywood4164 Heywood4164 2 years ago
Federal legalization buries cresco in a deep dark grave, sorry for my friends here who didn’t offload at $12-$14
👍️0
happyglass happyglass 2 years ago
Never bad to trade around a core if you can see the patterns. I find I am safer to just hold on most of my stuff. More successful for me that way
👍️0
owg2 owg2 2 years ago
So, anyone else looking to take a little profit from the 4/20 run-up?
👍️0
FUNMAN FUNMAN 2 years ago
CRESCO's PPS suffers as Dems stumble--->>>POLITICS - Schumer’s Marijuana Legalization Bill Not Coming This Month, As Senators Work To Finalize Provisions

Published 15 hours ago on April 14, 2022

https://www.marijuanamoment.net/schumers-marijuana-legalization-bill-not-coming-this-month-as-senators-work-to-finalize-provisions/

The long-anticipated Senate bill to federally legalize marijuana will not be introduced this month, with Democratic leadership saying on Thursday that the timeline is being extended as they continue to work out various provisions “with the assistance of nearly a dozen Senate committees and input from numerous federal agencies.”

Senate Majority Leader Chuck Schumer (D-NY) has said on several occasions that the bill he’s been working on with Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) for many months would be formally filed by the end of April. That’s no longer the case, with the leader now saying the “official introduction” will take place sometime “before the August recess.”

A discussion draft of the Cannabis Administration & Opportunity Act (CAOA) was first unveiled last year, and advocates and stakeholders have been hanging on the leader’s words as they continue to push for an end to federal prohibition. Most recently, Schumer said last week that he and colleagues were in the process of reaching out to Republican senators to “see what they want” included in the legislation.

The timeline that Schumer previewed has apparently proved too ambitious—but the hope is that by taking extra time to finalize the measure, it will help the senators overcome what are currently significant odds stacked against them to reach a high vote threshold in the chamber, where Democrats hold just a slim majority and several members of the party have indicated that they’re not supportive of legalization.

CAOA is is “critical legislation that will finally put an end to the federal prohibition on cannabis and address the over-criminalization of cannabis in a comprehensive and meaningful way,” Schumer said in a press release. “I am proud of the progress made in bringing this vital bill closer to its official introduction before the August recess, and I want to thank the committee chairs who have worked with us and remained committed to addressing this issue.”

“CAOA will not only remove cannabis from the federal list of controlled substances, but also help repair our criminal justice system, ensure restorative justice, protect public health, and implement responsible taxes and regulations,” he said.

In the process of finalizing key provisions, working to build consensus with committee leadership and GOP members, the Senate sponsors detailed “key policies” of the bill that are being taken into consideration, including some that advocates would support that weren’t included in the discussion draft such as removing or scaling back drug testing for cannabis for certain federal workers.

Here’s a list of those policy areas that are being looked at as the senators continue to work the bill:

• Removing unnecessary federal employee pre-employment and random drug testing for cannabis, while preserving appropriate drug testing in transportation-related fields, other sensitive areas of employment, and investigations of accidents and unsafe practices.

• Specifying membership and duties of the Cannabis Products Advisory Committee, an entity created in the legislation which FDA would convene and consult before promulgating regulations.

• Clarifying market competition rules meant to protect independent retailers and prevent anti-competitive behavior, to ensure that those rules do not unintentionally undermine state programs that provide access to capital for social equity businesses.

• Broad review of agricultural and environmental laws applicable to cannabis, and working to ensure that appropriate environmental protections apply to cannabis production.

• Ensuring worker protections for those employed in the cannabis industry.

• Ensuring regulatory bodies and law enforcement have the resources and tools they need to protect the integrity of the legal cannabis marketplace.

• Strengthening cannabis business protections and opportunities under Small Business Administration programs.

• Clarifying the relationship between state governments and Indian tribal governments with respect to cannabis.

• Broad review of existing law to cannabis throughout the government, and developing a variety of additional policies to ensure consistent and appropriate treatment of cannabis.

“The federal cannabis ban is a senseless and failed relic that’s needlessly destroyed lives, stifled research and treated job-generating legal small businesses in Oregon and other states like criminal organizations,” Wyden said. “This outdated prohibition is long overdue for an end. And introducing final legislation as early as possible requires committees to continue their diligent work, and agencies to provide prompt analysis.”

“Simply put, final text of this urgently needed legislation must be released well before the August recess to continue building momentum for cannabis reform,” he said.

Booker, for his part, said that as more and more states move to legalize cannabis, “Congress must enact comprehensive cannabis reform that will deliver restorative justice to communities to undo the harms of America’s failed drug policies.”

“After months of substantive progress we are close to finalizing a bill that reflects common sense drug policy and delivers long overdue justice,” the senator said.

This development comes weeks after the U.S. House of Representatives approved a separate bill to federally legalize marijuana and promote social equity, the Marijuana Opportunity, Reinvestment and Expungement (MORE) Act from Judiciary Committee Jerrold Nadler (D-NY).

The largely partisan vote on that legislation, which saw only three Republicans vote in favor of passage, speaks to the challenges that a similar Senate bill might face, especially in the draft version released last year.

Meanwhile, several Republican members of Congress introduced a bill last November to federally legalize and tax marijuana as an alternative to far-reaching Democratic-led reform proposals and scaled-down GOP cannabis descheduling legislation. The sponsor of that bill, Rep. Nancy Mace (R-SC), said she expects a committee hearing on her proposal.

On Thursday, a bipartisan group of congressional lawmakers filed a bill that would simply direct the attorney general to create a commission charged with making recommendations on a regulatory system for marijuana that models what’s currently in place for alcohol.

Reps. Dave Joyce (R-OH), Hakeem Jeffries (D-NY) and Brian Mast (R-FL) are teaming up on what’s titled the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (PREPARE) Act—an incremental reform meant to inform comprehensive cannabis policy changes in the future.
👍️0

Your Recent History

Delayed Upgrade Clock